Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation*

Nod2, a member of the Apaf1/Nod protein family, confers responsiveness to bacterial products and activates NF-κB, a transcription factor that plays a central role in innate immunity. Recently, genetic variation in Nod2 has been associated with susceptibility to Crohn's disease. Here, we report that expression of Nod2 is induced upon differentiation of CD34+hematopoietic progenitor cells into granulocyte or monocyte/macrophages. In peripheral blood cells, the highest levels of Nod2 were observed in CD14+ (monocytes), CD15+(granulocytes), and CD40+/CD86+ (dendritic cells) cell populations. Notably, stimulation of myeloblastic and epithelial cells with bacterial lipopolysaccharide or TNFα resulted in up-regulation of Nod2. A search for consensus sites within the Nod2 promoter revealed a NF-κB binding element that was required for transcriptional activity in response to TNFα. Moreover, ectopic expression of p65 induced transactivation, whereas that of dominant-negative IκBα blocked the transcriptional activity of the Nod2 promoter. Upon stimulation with TNFα or lipopolysaccharide, both p50 and p65 subunits of NF-κB were bound to the Nod2 promoter. Thus, Nod2 expression is enhanced by proinflammatory cytokines and bacterial components via NF-κB, a mechanism that may contribute to the amplification of the innate immune response and susceptibility to inflammatory disease.

[1]  S. Akira,et al.  Roles of Toll‐like receptors in innate immune responses , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[2]  F C Kafatos,et al.  Phylogenetic perspectives in innate immunity. , 1999, Science.

[3]  T. Maniatis,et al.  NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .

[4]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[5]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[6]  Jiahuai Han,et al.  Glucocorticoids Synergistically Enhance NontypeableHaemophilus influenzae-induced Toll-like Receptor 2 Expression via a Negative Cross-talk with p38 MAP Kinase* , 2002, The Journal of Biological Chemistry.

[7]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[8]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[9]  C. Elson Genes, microbes, and T cells--new therapeutic targets in Crohn's disease. , 2002, The New England journal of medicine.

[10]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[11]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[12]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 , 2000, The Journal of Immunology.

[13]  A. Young,et al.  Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination , 2000 .

[14]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[15]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[16]  J. Weber,et al.  Phase I Trial Of Intravenous Peptide-Pulsed Dendritic Cells in Patients With Metastatic Melanoma , 2001, Journal of immunotherapy.

[17]  J. Kennell,et al.  Dendritic Cell-specific MHC Class II Transactivator Contains a Caspase Recruitment Domain That Confers Potent Transactivation Activity* , 2001, The Journal of Biological Chemistry.

[18]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.

[19]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[20]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[21]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[22]  R. Jove,et al.  Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  J. Segovia,et al.  The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. , 1997, Blood.

[24]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[25]  S. Ghosh,et al.  Signal transduction through NF-κB , 1998 .

[26]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[27]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[28]  Y. Ogura,et al.  Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.

[29]  G. Cheng,et al.  Involvement of receptor-interacting protein 2 in innate and adaptive immune responses , 2002, Nature.

[30]  L. del Peso,et al.  Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.

[31]  G. Núñez,et al.  Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. , 1996, Blood.